Fair Value Measurements (Tables)

9 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Fair Value of Financial Instruments Measured at Fair Value on Recurring Basis

The following table presents the fair value of the Company’s financial instruments (in thousands):

	March 31, 2024								June 30, 2023
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets:
Money market funds	$	2,191	$	—	$	—	$	2,191	$	16,910	$	—	$	—	$	16,910
Total	$	2,191	$	—	$	—	$	2,191	$	16,910	$	—	$	—	$	16,910
Liabilities:
Post-closing payments related to acquisitions	$	—	$	18,532	$	—	$	18,532	$	—	$	17,498	$	—	$	17,498
Contingent consideration related to acquisitions		—		—		2,467		2,467		—		—		1,039		1,039
Total	$	—	$	18,532	$	2,467	$	20,999	$	—	$	17,498	$	1,039	$	18,537
Reported as:
Cash and cash equivalents							$	2,191							$	16,910
Other Liabilities:
Current							$	9,883							$	7,875
Noncurrent								11,116								10,662
Total							$	20,999							$	18,537

Schedule of Change in Contingent Consideration

The following table represents the changes in the contingent consideration during the three and nine months ended March 31, 2024 (in thousands):

	Three Months Ended			Nine Months Ended
	March 31, 2024			March 31, 2024
Balance at the beginning of period	$	711		$	1,039
Changes in fair value during the period		—			—
Payments made during the period		(344	)		(672	)
Balance at the end of period	$	367		$	367